255 related articles for article (PubMed ID: 31842295)
1. Molecular and Cellular Mechanisms of Melatonin in Osteosarcoma.
Lu KH; Lin RC; Yang JS; Yang WE; Reiter RJ; Yang SF
Cells; 2019 Dec; 8(12):. PubMed ID: 31842295
[TBL] [Abstract][Full Text] [Related]
2. Potential Mechanisms of Melatonin in Osteosarcoma and Bone-Related Neoplasms: Updated Review.
Dana PM; Sadoughi F; Reiter RJ; Yousefi B; Asemi Z
Mini Rev Med Chem; 2023; 23(3):290-297. PubMed ID: 35726422
[TBL] [Abstract][Full Text] [Related]
3. Melatonin in osteosarcoma: an effective drug?
Panzer A
Med Hypotheses; 1997 Jun; 48(6):523-5. PubMed ID: 9247897
[TBL] [Abstract][Full Text] [Related]
4. Molecular Mechanism of Gas Anesthetics on the Invasion, Metastasis, and Chemosensitivity of Osteosarcoma Cells.
Zhao Q; Yan J; Li W; Yang Y; You L; Qin C
Comput Math Methods Med; 2021; 2021():6000385. PubMed ID: 34777566
[TBL] [Abstract][Full Text] [Related]
5. Anticancer effects of melatonin via regulating lncRNA JPX-Wnt/β-catenin signalling pathway in human osteosarcoma cells.
Li Y; Zou J; Li B; Du J
J Cell Mol Med; 2021 Oct; 25(20):9543-9556. PubMed ID: 34547170
[TBL] [Abstract][Full Text] [Related]
6. Melatonin attenuates osteosarcoma cell invasion by suppression of C-C motif chemokine ligand 24 through inhibition of the c-Jun N-terminal kinase pathway.
Lu KH; Su SC; Lin CW; Hsieh YH; Lin YC; Chien MH; Reiter RJ; Yang SF
J Pineal Res; 2018 Oct; 65(3):e12507. PubMed ID: 29766567
[TBL] [Abstract][Full Text] [Related]
7. Unveiling the Protective Role of Melatonin in Osteosarcoma: Current Knowledge and Limitations.
Al-Ansari N; Samuel SM; Büsselberg D
Biomolecules; 2024 Jan; 14(2):. PubMed ID: 38397382
[TBL] [Abstract][Full Text] [Related]
8. Salidroside suppresses the growth and invasion of human osteosarcoma cell lines MG63 and U2OS in vitro by inhibiting the JAK2/STAT3 signaling pathway.
Huang L; Huang Z; Lin W; Wang L; Zhu X; Chen X; Yang S; Lv C
Int J Oncol; 2019 Jun; 54(6):1969-1980. PubMed ID: 31081055
[TBL] [Abstract][Full Text] [Related]
9. Punicalagin inhibited proliferation, invasion and angiogenesis of osteosarcoma through suppression of NF‑κB signaling.
Huang T; Zhang X; Wang H
Mol Med Rep; 2020 Sep; 22(3):2386-2394. PubMed ID: 32705250
[TBL] [Abstract][Full Text] [Related]
10. Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of VEGFR2 and MET in osteosarcoma.
Wang G; Sun M; Jiang Y; Zhang T; Sun W; Wang H; Yin F; Wang Z; Sang W; Xu J; Mao M; Zuo D; Zhou Z; Wang C; Fu Z; Wang Z; Duan Z; Hua Y; Cai Z
Int J Cancer; 2019 Aug; 145(4):979-993. PubMed ID: 30719715
[TBL] [Abstract][Full Text] [Related]
11. SIRT1 inhibition by melatonin exerts antitumor activity in human osteosarcoma cells.
Cheng Y; Cai L; Jiang P; Wang J; Gao C; Feng H; Wang C; Pan H; Yang Y
Eur J Pharmacol; 2013 Sep; 715(1-3):219-29. PubMed ID: 23726949
[TBL] [Abstract][Full Text] [Related]
12. Sinomenine prevents metastasis of human osteosarcoma cells via S phase arrest and suppression of tumor-related neovascularization and osteolysis through the CXCR4-STAT3 pathway.
Xie T; Ren HY; Lin HQ; Mao JP; Zhu T; Wang SD; Ye ZM
Int J Oncol; 2016 May; 48(5):2098-112. PubMed ID: 26983669
[TBL] [Abstract][Full Text] [Related]
13. EGFR is not a major driver for osteosarcoma cell growth in vitro but contributes to starvation and chemotherapy resistance.
Sevelda F; Mayr L; Kubista B; Lötsch D; van Schoonhoven S; Windhager R; Pirker C; Micksche M; Berger W
J Exp Clin Cancer Res; 2015 Nov; 34():134. PubMed ID: 26526352
[TBL] [Abstract][Full Text] [Related]
14. New insights into molecular and cellular mechanisms of zoledronate in human osteosarcoma.
Lu KH; Lu EW; Lin CW; Yang JS; Yang SF
Pharmacol Ther; 2020 Oct; 214():107611. PubMed ID: 32565177
[TBL] [Abstract][Full Text] [Related]
15. Melatonin inhibits osteosarcoma stem cells by suppressing SOX9-mediated signaling.
Qu H; Xue Y; Lian W; Wang C; He J; Fu Q; Zhong L; Lin N; Lai L; Ye Z; Wang Q
Life Sci; 2018 Aug; 207():253-264. PubMed ID: 29689273
[TBL] [Abstract][Full Text] [Related]
16. Emetine exerts anticancer effects in U2OS human osteosarcoma cells via activation of p38 and inhibition of ERK, JNK, and β-catenin signaling pathways.
Son J; Lee SY
J Biochem Mol Toxicol; 2021 Oct; 35(10):e22868. PubMed ID: 34338395
[TBL] [Abstract][Full Text] [Related]
17. The Anthelmintic Drug Niclosamide Inhibits the Proliferative Activity of Human Osteosarcoma Cells by Targeting Multiple Signal Pathways.
Liao Z; Nan G; Yan Z; Zeng L; Deng Y; Ye J; Zhang Z; Qiao M; Li R; Denduluri S; Wang J; Wei Q; Geng N; Zhao L; Lu S; Wang X; Zhou G; Luu HH; Haydon RC; He TC; Wang Z
Curr Cancer Drug Targets; 2015; 15(8):726-38. PubMed ID: 26118906
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosis.
Murahari S; Jalkanen AL; Kulp SK; Chen CS; Modiano JF; London CA; Kisseberth WC
BMC Cancer; 2017 Jan; 17(1):67. PubMed ID: 28109246
[TBL] [Abstract][Full Text] [Related]
19. β-Elemonic acid inhibits the growth of human Osteosarcoma through endoplasmic reticulum (ER) stress-mediated PERK/eIF2α/ATF4/CHOP activation and Wnt/β-catenin signal suppression.
Zhao A; Zhang Z; Zhou Y; Li X; Li X; Ma B; Zhang Q
Phytomedicine; 2020 Apr; 69():153183. PubMed ID: 32113150
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells.
Castro-Gamero AM; Borges KS; da Silva Silveira V; Lira RC; de Paula Gomes Queiroz R; Valera FC; Scrideli CA; Umezawa K; Tone LG
Anticancer Drugs; 2012 Jul; 23(6):638-50. PubMed ID: 22382389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
